What Is Cronos Group Inc. Common Share (CRON) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Cronos Group Inc. Common Share's intrinsic value is estimated at a composite $2.95, showing conflicting signals at the current price of $2.74. While the average implied return is +7.5%, model disagreement is elevated with a gap of +214.0% between the most bullish and bearish estimates. The most optimistic model, EPV, places fair value at $6.16 (+124.6%), while Regime Cross — the most conservative — estimates $0.29 (-89.4%). This +214.0% gap reflects genuine analytical uncertainty about Cronos Group Inc. Common Share's intrinsic worth. Among models with highest confidence, EPV lean bullish — adding weight to the bullish side of the thesis.
What Do the Models Say About CRON?
12 of 13 models are currently active for CRON. Of these, 5 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates CRON's intrinsic value at $2.61, implying -4.6% downside from the current price. See which stocks rank higher →
How Does CRON Rank in Medicinal Chemicals & Botanical Products?
Among 17 Medicinal Chemicals & Botanical Products stocks, CRON ranks #10 by Quality of Company score. CirclFi's QOC score of 5.3/10 evaluates 32 fundamental signals. A score of 5.3 reflects mixed fundamentals.
The Medicinal Chemicals & Botanical Products sector introduces analytical considerations specific to industrial businesses. For Cronos Group Inc. Common Share, metrics like margin expansion trajectory provide important context that general-purpose valuation models may underweight.
Is CRON a Value Trap?
CirclFi's Value Trap algorithm assigns CRON a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Cronos Group Inc. Common Share. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Cronos Group Inc. Common Share scores 5.3 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +214.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CRON valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CRON's 12 active models, average confidence is 41%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad